About: Dimitri Azar     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikidata:Q901, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FDimitri_Azar&graph=http%3A%2F%2Fdbpedia.org&graph=http%3A%2F%2Fdbpedia.org

Dimitri Azar M.D. (born 1959) is an American ophthalmologist, professor, and businessman who leads Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. Dr. Azar has held roles at Novartis and Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018.

AttributesValues
rdf:type
rdfs:label
  • Dimitri Azar (en)
rdfs:comment
  • Dimitri Azar M.D. (born 1959) is an American ophthalmologist, professor, and businessman who leads Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. Dr. Azar has held roles at Novartis and Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018. (en)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/Dimitri_Azar_Headshot.png
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
workplaces
  • University of Illinois at Chicago; American Ophthalmological Society; Chicago Ophthalmological Society; Chicago Medical Society; Association of Research in Vision and Ophthalmology; Verily; Verb Surgical Inc; Tear Film and Ocular Surface Society; Novartis (en)
dbp:wikiPageUsesTemplate
thumbnail
alma mater
  • American University of Beirut, Lebanon; Wilmer Eye Institute, Johns Hopkins Hospital School of Medicine; Massachusetts Eye and Ear Infirmary, Harvard Medical School; University of Chicago Booth School of Business (en)
birth date
date
fields
  • Ophthamology (en)
url
has abstract
  • Dimitri Azar M.D. (born 1959) is an American ophthalmologist, professor, and businessman who leads Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. Dr. Azar has held roles at Novartis and Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018. (en)
institution
prov:wasDerivedFrom
page length (characters) of wiki page
alma mater
foaf:isPrimaryTopicOf
is Link from a Wikipage to another Wikipage of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (61 GB total memory, 47 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software